AT
PFE icon

Arvest Trust’s Pfizer PFE Stock Holding History

Arvest Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$13.6M Sell
485,907
-17,344
-3% -$478K 0.81% 44
2024
Q1 		$14M Sell
503,251
-837
-0.2% -$23.2K 0.79% 44
2023
Q4 		$14.5M Buy
504,088
+180,188
+56% +$5.45M 0.87% 40
2023
Q3 		$10.7M Sell
323,900
-2,833
-0.9% -$100K 0.7% 48
2023
Q2 		$11.8M Sell
326,733
-8,148
-2% -$317K 0.7% 47
2023
Q1 		$13.7M Sell
334,881
-10,525
-3% -$455K 0.85% 40
2022
Q4 		$17.7M Sell
345,406
-19,344
-5% -$927K 1.11% 28
2022
Q3 		$16M Buy
364,750
+24,855
+7% +$1.21M 1.1% 29
2022
Q2 		$17.8M Sell
339,895
-6,187
-2% -$315K 1.17% 28
2022
Q1 		$17.9M Sell
346,082
-1,336
-0.4% -$69.3K 1% 35
2021
Q4 		$20.5M Buy
+347,418
New +$17.2M 1.08% 31
2014
Q2 		$12.8M Buy
455,791
+701
+0.2% +$20K 1.19% 31
2014
Q1 		$13.5M Sell
455,090
-5,583
-1% -$166K 1.3% 27
2013
Q4 		$13.4M Sell
460,673
-11,263
-2% -$328K 1.33% 29
2013
Q3 		$12.9M Sell
471,936
-4,159
-0.9% -$113K 1.41% 28
2013
Q2 		$12.7M Buy
+476,095
New +$13.2M 1.45% 28

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Arvest Trust's PFE Position: Q2 2024 in Review

Arvest Trust reduced its Pfizer (PFE) stake by 3.4% in Q2 2024, selling an estimated $478K and leaving 485,907 shares worth $13.6M. The position accounts for 0.81% of the portfolio, ranked #44.

Arvest Trust first reported a position in PFE in Q2 2013 and has held it in 16 quarters since. The position peaked at $20.5M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Arvest Trust held 485,907 shares of Pfizer worth $13.6M as of Q2 2024.
  • Arvest Trust sold 17,344 Pfizer shares in Q2 2024, an estimated $478K.
  • Pfizer made up 0.81% of Arvest Trust's portfolio in Q2 2024, its #44 holding.
  • Arvest Trust first reported a position in Pfizer in Q2 2013 and has held it in 16 quarters since.
  • Arvest Trust's Pfizer position peaked at $20.5M in Q4 2021.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Arvest Trust's 13F filing for Q2 2024, filed 9 Aug 2024.